跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHESGO 600 MG/600 MG SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PHESGO 600 MG/600 MG SOLUCION INYECTABLE
Approved
STANDARD
PHESGO 600 MG/600 MG SOLUCION INYECTABLE
Roche Registration Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 9, 2021
Approval ID
3cbbf7077361359b
Company
Roche Registration Gmbh
Type
Standard
Approval Details
Approval Id
3cbbf7077361359b
Drug Cima Aemps Name
PHESGO 600 MG/600 MG SOLUCION INYECTABLE
Register Number
1201497002
Holder Company Name
Roche Registration Gmbh
Marketing Company Name
Roche Farma S.A.
Holder Company Detail Path
/organization/roche-registration-gmbh
Authorization Date
2021-02-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
1200 - REVISAR mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Roche Registration Gmbh
Company Detail Path
/organization/roche-registration-gmbh
Company Information
Pharmaceutical Company Name
Roche Registration GmbH
Country Name
Germany
City Name
grenzach-wyhlen,baden-württemberg,country_de
Address
Emil-Barell-Str. 1
Active Ingredients
PERTUZUMAB
600 mg
TRASTUZUMAB
600 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 9, 2021
Approval ID
3cbbf7077361359b
Type
Standard
Back to CIMA-AEMPS Approvals